Mortality during Polymicrobial Sepsis Intestinal Barrier Dysfunction and Increased Cyclooxygenase-2 Deficiency Leads to

Sepsis remains the leading cause of death in critically ill patients, despite modern advances in critical care. Intestinal barrier dysfunction may lead to secondary bacterial translocation and the development of the multiple organ dysfunction syndrome during sepsis. Cyclooxygenase (COX)-2 is highly upregulated in the intestine during sepsis, and we hypothesized that it may be critical in the maintenance of intestinal epithelial barrier function during peritonitis-induced polymicrobial sepsis. COX-2 2 / 2 and COX-2 +/+ BALB/c mice underwent cecal ligation and puncture (CLP) or sham surgery. Mice chimeric for COX-2 were derived by bone marrow transplantation and underwent CLP. C2BBe1 cells, an intestinal epithelial cell line, were treated with the COX-2 inhibitor NS-398, PGD 2 , or vehicle and stimulated with cytokines. COX-2 2 / 2 mice developed exaggerated bacteremia and increased mortality compared with COX-2 +/+ mice following CLP. Mice chimeric for COX-2 exhibited the recipient phenotype, suggesting that epithelial COX-2 expression in the ileum attenuates bacteremia following CLP. Absence of COX-2 significantly increased epithelial permeability of the ileum and reduced expression of the tight junction proteins zonula occludens-1, occludin, and claudin-1 in the ileum following CLP. Furthermore, PGD 2 attenuated cytokine-induced hyperpermeability and zonula occludens-1 downregulation in NS-398–treated C2BBe1 cells. Our findings reveal that absence of COX-2 is associated with enhanced intestinal epithelial permeability and leads to exaggerated bacterial translocation and increased mortality during peritonitis-induced sepsis. Taken together, our results suggest that epithelial expression of COX-2 in the ileum is a critical modulator of tight junction protein expression and intestinal barrier function during sepsis. The Journal of Immunology , 2011, 187: 000–000.

[1]  M. Frey,et al.  TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[2]  A. Norrby-Teglund,et al.  Inducible Cyclooxygenase Released Prostaglandin E2 Modulates the Severity of Infection Caused by Streptococcus pyogenes , 2010, The Journal of Immunology.

[3]  M. Washington,et al.  p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. , 2010, The Journal of clinical investigation.

[4]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[5]  L. Lindgren,et al.  Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  A. M. Houghton,et al.  Macrophage elastase kills bacteria within murine macrophages , 2009, Nature.

[7]  M. Boivin,et al.  Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.

[8]  Jun Luo,et al.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis , 2008, Modern Pathology.

[9]  D. Artis Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.

[10]  D. Ingber,et al.  Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells , 2008, Circulation.

[11]  S. Chung,et al.  Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.

[12]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[13]  H. Kleinert,et al.  Regulation of cyclooxygenase-2 expression by cyclic AMP. , 2007, Biochimica et biophysica acta.

[14]  J. Christman,et al.  Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2 , 2007, European journal of immunology.

[15]  A. Blikslager,et al.  Restoration of barrier function in injured intestinal mucosa. , 2007, Physiological reviews.

[16]  D. Aronoff,et al.  Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.

[17]  C. Macias,et al.  HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. , 2006, American journal of physiology. Cell physiology.

[18]  R. Poulsom,et al.  Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis. , 2006, Carcinogenesis.

[19]  D. Remick,et al.  EVALUATION OF ENDOTOXIN MODELS FOR THE STUDY OF SEPSIS , 2005, Shock.

[20]  James J. Lee,et al.  Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[21]  L. Fredenburgh,et al.  Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. , 2005, Cellular and molecular biology.

[22]  V. Théodorou,et al.  Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. , 2005, The American journal of pathology.

[23]  T. Brzozowski,et al.  Role of prostaglandins in gastroprotection and gastric adaptation. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[24]  J. Wallace,et al.  Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense , 2005, British journal of pharmacology.

[25]  M. Fink,et al.  Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. , 2005, Critical care clinics.

[26]  R. Griffiths,et al.  Intestinal permeability in the critically ill , 2005, Intensive Care Medicine.

[27]  E. Ingenito,et al.  Nitric oxide synthase‐2 down‐regulates surfactant protein‐B expression and enhances endotoxin‐induced lung injury in mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  D. Aronoff,et al.  Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.

[29]  V. Angeli,et al.  Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. , 2004, Critical reviews in immunology.

[30]  M. Fink,et al.  IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[31]  B. Levy,et al.  Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Fink,et al.  Proinflammatory Cytokines Cause No·-Dependent and -Independent Changes in Expression and Localization of Tight Junction Proteins in Intestinal Epithelial Cells , 2003, Shock.

[33]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[34]  M. Fink,et al.  Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers , 2003, Journal of Pharmacology and Experimental Therapeutics.

[35]  A. Nathens,et al.  Risk factors for severe sepsis in secondary peritonitis. , 2003, Surgical infections.

[36]  M. Freeman,et al.  Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 , 2002, The Journal of Immunology.

[37]  M. Fink,et al.  Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[38]  Yoshihiro Urade,et al.  Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.

[39]  J. Wallace PROSTAGLANDIAN BIOLOGY IN INFLAMMATORY BOWEL DISEASE , 2001 .

[40]  B. Schreiber,et al.  Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  T. Standiford,et al.  Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[42]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[43]  B. Schreiber,et al.  Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  H. Rennke,et al.  Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.

[45]  R. Hershberg,et al.  Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.

[46]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[47]  J. Wallace Prostaglandin biology in inflammatory bowel disease. , 2001, Gastroenterology clinics of North America.

[48]  C. Houchen,et al.  Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[49]  J. Wallace,et al.  NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.

[50]  T. Uliasz,et al.  A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture , 2000, Journal of Neuroscience Methods.

[51]  J. Wallace,et al.  Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[52]  R. Sartor,et al.  Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. , 2000, The Journal of clinical investigation.

[53]  Rian,et al.  THE EFFECTS OF IBUPROFEN ON THE PHYSIOLOGY AND SURVIVAL OF PATIENTS WITH SEPSIS , 2000 .

[54]  M. Respondek,et al.  Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach , 1999, British journal of pharmacology.

[55]  M. Fink,et al.  Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. , 1999, Shock.

[56]  A. Ford-hutchinson,et al.  A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. , 1999, European journal of pharmacology.

[57]  Han,et al.  Specific NF‐κB blockade selectively inhibits tumour necrosis factor‐α‐induced COX‐2 but not constitutive COX‐1 gene expression in HT‐29 cells , 1998, Immunology.

[58]  C. Koboldt,et al.  Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Doig,et al.  Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. , 1998, American journal of respiratory and critical care medicine.

[60]  J. Mazuski,et al.  Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. , 1998, Prostaglandins & other lipid mediators.

[61]  I. Singer,et al.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.

[62]  J. R. Smith,et al.  Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.

[63]  H. Sheng,et al.  Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[64]  G. Bernard,et al.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.

[65]  K. Seibert,et al.  Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.

[66]  J. Wallace,et al.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.

[67]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[68]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[69]  H. Chan,et al.  Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.

[70]  S. Narumiya,et al.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Rodning,et al.  Tumor Necrosis Factor‐Induced Mortality Is Reversed with Cyclooxygenase Inhibition , 1993, Annals of surgery.

[72]  P. Rangachari,et al.  Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. , 1991, The American journal of physiology.

[73]  U. Haglund,et al.  The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. , 1990, Surgery.

[74]  Y. Urade,et al.  Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.

[75]  W. Stok,et al.  Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. , 1987, Journal of immunological methods.

[76]  T. Grosser,et al.  PROSTANOIDS IN HEALTH AND DISEASE , 1979 .

[77]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.

[78]  M. Frey,et al.  TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[79]  A. Norrby-Teglund,et al.  Inducible Cyclooxygenase Released Prostaglandin E2 Modulates the Severity of Infection Caused by Streptococcus pyogenes , 2010, The Journal of Immunology.

[80]  M. Washington,et al.  p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. , 2010, The Journal of clinical investigation.

[81]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[82]  L. Lindgren,et al.  Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[83]  A. M. Houghton,et al.  Macrophage elastase kills bacteria within murine macrophages , 2009, Nature.

[84]  M. Boivin,et al.  Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.

[85]  Jun Luo,et al.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis , 2008, Modern Pathology.

[86]  D. Artis Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.

[87]  D. Ingber,et al.  Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells , 2008, Circulation.

[88]  S. Chung,et al.  Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.

[89]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[90]  H. Kleinert,et al.  Regulation of cyclooxygenase-2 expression by cyclic AMP. , 2007, Biochimica et biophysica acta.

[91]  J. Christman,et al.  Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2 , 2007, European journal of immunology.

[92]  A. Blikslager,et al.  Restoration of barrier function in injured intestinal mucosa. , 2007, Physiological reviews.

[93]  D. Aronoff,et al.  Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.

[94]  C. Macias,et al.  HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. , 2006, American journal of physiology. Cell physiology.

[95]  R. Poulsom,et al.  Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis. , 2006, Carcinogenesis.

[96]  D. Remick,et al.  EVALUATION OF ENDOTOXIN MODELS FOR THE STUDY OF SEPSIS , 2005, Shock.

[97]  James J. Lee,et al.  Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[98]  L. Fredenburgh,et al.  Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. , 2005, Cellular and molecular biology.

[99]  V. Théodorou,et al.  Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. , 2005, The American journal of pathology.

[100]  T. Brzozowski,et al.  Role of prostaglandins in gastroprotection and gastric adaptation. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[101]  J. Wallace,et al.  Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense , 2005, British journal of pharmacology.

[102]  M. Fink,et al.  Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. , 2005, Critical care clinics.

[103]  R. Griffiths,et al.  Intestinal permeability in the critically ill , 2005, Intensive Care Medicine.

[104]  E. Ingenito,et al.  Nitric oxide synthase‐2 down‐regulates surfactant protein‐B expression and enhances endotoxin‐induced lung injury in mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[105]  D. Aronoff,et al.  Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.

[106]  V. Angeli,et al.  Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. , 2004, Critical reviews in immunology.

[107]  M. Fink,et al.  IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[108]  B. Levy,et al.  Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  M. Fink,et al.  Proinflammatory Cytokines Cause No·-Dependent and -Independent Changes in Expression and Localization of Tight Junction Proteins in Intestinal Epithelial Cells , 2003, Shock.

[110]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[111]  M. Fink,et al.  Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers , 2003, Journal of Pharmacology and Experimental Therapeutics.

[112]  A. Nathens,et al.  Risk factors for severe sepsis in secondary peritonitis. , 2003, Surgical infections.

[113]  M. Freeman,et al.  Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 , 2002, The Journal of Immunology.

[114]  M. Fink,et al.  Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[115]  Yoshihiro Urade,et al.  Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.

[116]  B. Schreiber,et al.  Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[117]  T. Standiford,et al.  Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[118]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[119]  H. Rennke,et al.  Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.

[120]  R. Hershberg,et al.  Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.

[121]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[122]  J. Wallace Prostaglandin biology in inflammatory bowel disease. , 2001, Gastroenterology clinics of North America.

[123]  C. Houchen,et al.  Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[124]  J. Wallace,et al.  NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.

[125]  T. Uliasz,et al.  A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture , 2000, Journal of Neuroscience Methods.

[126]  J. Wallace,et al.  Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[127]  R. Sartor,et al.  Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. , 2000, The Journal of clinical investigation.

[128]  Rian,et al.  THE EFFECTS OF IBUPROFEN ON THE PHYSIOLOGY AND SURVIVAL OF PATIENTS WITH SEPSIS , 2000 .

[129]  M. Respondek,et al.  Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach , 1999, British journal of pharmacology.

[130]  M. Fink,et al.  Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. , 1999, Shock.

[131]  A. Ford-hutchinson,et al.  A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. , 1999, European journal of pharmacology.

[132]  C. Koboldt,et al.  Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[133]  C. Doig,et al.  Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. , 1998, American journal of respiratory and critical care medicine.

[134]  J. Mazuski,et al.  Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. , 1998, Prostaglandins & other lipid mediators.

[135]  I. Singer,et al.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.

[136]  J. R. Smith,et al.  Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.

[137]  H. Sheng,et al.  Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[138]  K. Seibert,et al.  Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.

[139]  J. Wallace,et al.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.

[140]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[141]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[142]  H. Chan,et al.  Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.

[143]  S. Narumiya,et al.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[144]  C. Rodning,et al.  Tumor Necrosis Factor‐Induced Mortality Is Reversed with Cyclooxygenase Inhibition , 1993, Annals of surgery.

[145]  P. Rangachari,et al.  Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. , 1991, The American journal of physiology.

[146]  U. Haglund,et al.  The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. , 1990, Surgery.

[147]  Y. Urade,et al.  Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.

[148]  W. Stok,et al.  Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. , 1987, Journal of immunological methods.

[149]  T. Grosser,et al.  PROSTANOIDS IN HEALTH AND DISEASE , 1979 .

[150]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.